Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-21-000013
Filing Date
2021-02-04
Accepted
2021-02-04 19:42:26
Documents
1
Period of Report
2021-02-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3875
  Complete submission text file 0000886744-21-000013.txt   5343
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 651 GATEWAY BLVD STE 950 SOUTH SAN FRANCISCO CA 94080
Business Address
GRETHLEIN ANDREW J (Reporting) CIK: 0001270921 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 21592823